|
Real-time Estimate
Cboe BZX
18:11:01 22/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 100.46 USD | +2.51% |
|
+2.91% | +4.52% |
| 09-12 | Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing | MT |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
Company Valuation: BioNTech SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 54,749 | 34,159 | 22,698 | 26,387 | 19,497 | 21,464 | - | - |
| Change | - | -37.61% | -33.55% | 16.25% | -26.11% | 10.09% | - | - |
| Enterprise Value (EV) 1 | 53,358 | 20,496 | 11,253 | 16,879 | 12,356 | 10,096 | 11,436 | 12,032 |
| Change | - | -61.59% | -45.1% | 50% | -26.8% | -18.29% | 13.28% | 5.21% |
| P/E | 5.72x | 3.72x | 24.9x | -39.7x | -17.3x | -15x | -15.7x | -22x |
| PBR | 4.62x | 1.7x | 1.12x | - | 1.06x | 1.23x | 1.32x | 1.42x |
| PEG | - | -0.79x | -0.3x | 0x | -0.2x | -0.7x | 3.67x | 0.8x |
| Capitalization / Revenue | 2.89x | 1.97x | 5.94x | 9.59x | 6.79x | 11.9x | 11.9x | 9.35x |
| EV / Revenue | 2.81x | 1.18x | 2.95x | 6.14x | 4.31x | 5.59x | 6.31x | 5.24x |
| EV / EBITDA | 3.47x | 1.61x | 12.9x | -16.6x | -12.1x | -7.02x | -7.82x | -11.1x |
| EV / EBIT | 3.49x | 1.62x | 16.3x | -12.8x | -8.79x | -5.54x | -6.72x | -9.84x |
| EV / FCF | 72.5x | 1.55x | 2.41x | -69x | 44x | -5.78x | -5.86x | -6.99x |
| FCF Yield | 1.38% | 64.5% | 41.5% | -1.45% | 2.27% | -17.3% | -17.1% | -14.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 39.63 | 37.77 | 3.83 | -2.77 | -4.7 | -5.7 | -5.456 | -3.88 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,977 | 17,311 | 3,819 | 2,751 | 2,870 | 1,807 | 1,811 | 2,295 |
| EBITDA 1 | 15,359 | 12,766 | 873.8 | -1,016 | -1,022 | -1,437 | -1,462 | -1,080 |
| EBIT 1 | 15,284 | 12,643 | 690.4 | -1,314 | -1,405 | -1,822 | -1,703 | -1,223 |
| Net income 1 | 10,292 | 9,434 | 930.3 | -665.3 | -1,136 | -1,377 | -1,310 | -955.8 |
| Net Debt 1 | -1,391 | -13,663 | -11,445 | -9,508 | -7,141 | -11,369 | -10,028 | -9,433 |
| Reference price 2 | 226.68 | 140.56 | 95.48 | 110.06 | 81.08 | 85.45 | 85.45 | 85.45 |
| Nbr of stocks (in thousands) | 241,521 | 243,019 | 237,716 | 239,740 | 240,455 | 251,204 | - | - |
| Announcement Date | 30/03/22 | 27/03/23 | 20/03/24 | 10/03/25 | 10/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.99x | 5.59x | -7.02x | -.--% | 24.62B | |
| 21.82x | 7.74x | 15.55x | 1.36% | 74.33B | |
| 32.35x | 9.35x | 29.12x | 0.04% | 62.26B | |
| 32.02x | 6.83x | 17.73x | -.--% | 27.72B | |
| -73.86x | 14.28x | -68.86x | -.--% | 26.42B | |
| 28.25x | 5.33x | 17.69x | -.--% | 20.72B | |
| 43.37x | 15.89x | 32.23x | 0.35% | 15.01B | |
| 17.67x | 5.26x | 12.29x | -.--% | 14.18B | |
| -14.6x | 3288.74x | -16.82x | -.--% | 13.48B | |
| 1078x | 37.73x | 651.73x | -.--% | 15.1B | |
| Average | 115.00x | 339.67x | 68.36x | 0.17% | 29.38B | |
| Weighted average by Cap. | 67.28x | 160.61x | 41.20x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BNTX Stock
- Valuation BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
